AI boosts colon cancer screening in china trial
NCT ID NCT07261059
First seen Jan 06, 2026 · Last updated May 18, 2026 · Updated 20 times
Summary
This study tests whether artificial intelligence (AI) can help more high-risk adults aged 40 to 64 in China get a colonoscopy, the best way to find colorectal cancer early. About 400 participants will be split into two groups: one gets usual care, the other gets extra AI-assisted support from a team of specialists and general practitioners. The goal is to see if the AI approach increases screening rates and improves people's knowledge and beliefs about cancer screening.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.